Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$245K Sell
22,498
-3,058
-12% -$32.6K ﹤0.01% 938
2026
Q1
$284K Sell
25,556
-26,381
-51% -$336K ﹤0.01% 798
2025
Q4
$851K Sell
51,937
-37,058
-42% -$577K 0.01% 432
2025
Q3
$1.19M Buy
88,995
+75,945
+582% +$898K 0.01% 328
2025
Q2
$167K Sell
13,050
-2,325
-15% -$27.9K ﹤0.01% 538
2025
Q1
$158K Buy
15,375
+5,314
+53% +$68.4K ﹤0.01% 595
2024
Q4
$128K Sell
10,061
-32,842
-77% -$434K ﹤0.01% 594
2024
Q3
$549K Sell
42,903
-20,003
-32% -$245K 0.01% 290
2024
Q2
$798K Buy
62,906
+10,047
+19% +$174K 0.02% 244
2024
Q1
$1.2M Buy
52,859
+12,761
+32% +$299K 0.04% 169
2023
Q4
$996K Buy
+40,098
New +$783K 0.04% 223

Other funds holding PATH

Marex Group's PATH Position: Q2 2026 in Review

Marex Group reduced its UiPath (PATH) stake by 12% in Q2 2026, selling an estimated $32.6K and leaving 22,498 shares worth $245K. The position accounts for ﹤0.01% of the portfolio, ranked #938.

Marex Group first reported a position in PATH in Q4 2023 and has held it in 11 quarters since. The position peaked at $1.2M in Q1 2024. 526 funds tracked by Wall St. Rank hold PATH as of Q2 2026.

  • Marex Group held 22,498 shares of UiPath worth $245K as of Q2 2026.
  • Marex Group sold 3,058 UiPath shares in Q2 2026, an estimated $32.6K.
  • UiPath made up ﹤0.01% of Marex Group's portfolio in Q2 2026, its #938 holding.
  • Marex Group first reported a position in UiPath in Q4 2023 and has held it in 11 quarters since.
  • Marex Group's UiPath position peaked at $1.2M in Q1 2024.
  • 526 funds tracked by Wall St. Rank held UiPath as of Q2 2026.

Based on Marex Group's 13F filing for Q2 2026, filed 14 Aug 2026.